Large representation of RESCOLL at the French 2015 MEDTEC Fair in Besançon
Rescoll was an exhibitor at the 7th edition of Medtec France, a fair for medical devices of the French industry. This fair took place on June 10 and 11 in Besançon (MICROPOLIS exhibition complex). This event combines conferences and exhibitions and covers all technologies and skills of the medical device branch.
The MEDTEC Fair was the opportunity for Rescoll to emphasize its skills in terms of manufacturing (ISO 13485, CII), expertise, innovation (SRC, CRT, ISA13485), analysis and characterization (ISO 17025) in the biomaterial and medical devices sector. In addition, COFRAC accreditations for mechanical testing on bone screws (ASTM F543) ; ASTM F2077 on body fusion devices ; ASTM F2267 on body fusion devices ; ASTM F1717 on spinal implants ; ISO12189 on spinal implants ; ISO 7206-10 on assembly of stem/neck with modular head – were the subject of numerous demands.
In parallel, Elodie Pacard (Project Manager, Rescoll) and Magali Genet (Manager, Alcis) hosted a plenary conference about research works coming from FUI « HOBBIT » by RESCOLL, ALCIS, STATICE, NORAKER and IMP Lyon and MATEIS Laboratories. The neurosurgical applications were presented and largely appreciated by the attendees. The project aims to develop biomimetic and bioactive implants for bone reconstruction. The products manufacturing is based on composite technology (active ceramic and resorbable polymer) and uses the techniques of plastic processing (a project jointly certified by Plastipolis and microtechnical clusters and supported by FUI 8). This presentation will maybe enable Alcis to get financed to carry out a clinical study, which is essential before placing an implantable product on the market. Alcis innovation responds to a real clinical need in pediatric neurosurgery.
The great diversity of stakeholders attending the MEDTECH Fair allowed Rescoll to develop new contacts in the area of ophtalmology, orthopaedics, soft tissues and vascular surgery. The various exchanges allowed to discuss about ongoing research projects or projects to come.
For further information, please contact us at : email@example.com